Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation

Journal of Virology

Volumn 68, Issue 9, 1994, Pages 5411-5422

  Nussbaum, Ofer ^a   Broder, Christopher C ^a   Berger, Edward A ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; DEXTRAN SULFATE; ENVELOPE PROTEIN; GLYCOPROTEIN GP 120; HEPARAN SULFATE; MONOCLONAL ANTIBODY; OKT 4; RNA POLYMERASE; SIALIDASE; SOLUBLE CD4 ANTIGEN; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ARTICLE; BACTERIOPHAGE T7; CELL FUSION; CELL STRAIN 3T3; CONTROLLED STUDY; DOSE RESPONSE; GENE ACTIVATION; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MEMBRANE VESICLE; MOUSE; NONHUMAN; PARAMYXOVIRUS; PRIORITY JOURNAL; REPORTER GENE; VACCINIA VIRUS; VIRUS CELL INTERACTION; VIRUS INHIBITION; VIRUS RECOMBINANT;

EID: 0028129959     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.68.9.5411-5422.1994     Document Type: Article

References (46)

1. Alexander, W. A., B. Moss, and T. R. Fuerst. 1992. Regulated expression of foreign genes in vaccinia virus under the control of bacteriophage T7 RNA polymerase and the Escherichia coli lac repressor. J. Virol. 66:2934-2942.
2. Ashorn, P. A., E. A. Berger, and B. Moss. 1990. Human immunodeficiency virus envelope glycoprotein/CD4-mediated fusion of nonprimate cells with human cells. J. Virol. 64:2149-2156.
3. + cell types: studies using a novel recombinant vaccinia-based assay measuring reporter gene activation in fused cells. Abstr. p. 34. In Fifth International Conference on National Cooperative Drug Discovery Groups-HIV, Washington, D.C.
4. 3a.Broder, C. C., et al. Unpublished data.
5. Broder, C. C., D. S. Dimitrov, R. Blumenthal, and E. A. Berger. 1993. The block to HIV-1 envelope glycoprotein-mediated membrane fusion in animal cells expressing human CD4 can be overcome by a human cell component(s). Virology 193:483-491.
6. Broder, C. C., P. E. Kennedy, F. Michaels, and E. A. Berger. 1994. Expression of foreign genes in cultured human primary macrophages using recombinant vaccinia virus vectors. Gene 142:167-174.
7. Broder, C. C., O. Nussbaum, W. G. Gutheil, W. W. Bachovchin, and E. A. Berger. 1994. CD26 antigen and HIV fusion? Science 264:1156-1159.
8. + cells. Science 262:2045-2050.
9. 7a.Chakrabarti, S., and B. Moss (National Institute of Allergy and Infectious Diseases). Personal communication.
10. Cheng-Mayer, C., M. Quiroga, J. W. Tung, D. Dina, and J. A. Levy. 1990. Viral determinants of human immunodeficiency virus type 1 T-cell or macrophage tropism, cytopathogenicity, and CD4 antigen modulation. J. Virol. 64:4390-4398.
11. Ciminale, V., B. K. Felber, M. Campbell, and G. N. Pavlakis. 1990. A bioassay for HIV-1 based on Env-CD4 interaction. AIDS Res. Hum. Retroviruses 6:1281-1287.
12. Clapham, P. R., D. Blanc, and R. A. Weiss. 1991. Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by simian immunodeficiency virus. Virology 181:703-715.
13. Collman, R., and N. Nathanson. 1992. Human immunodeficiency virus type-1 infection of macrophages. Semin. Virol. 3:185-202.
14. Cullen, B. R., and E. D. Garrett. 1992. A comparison of regulatory features in primate lentiviruses. AIDS Res. Hum. Retroviruses 8:387-393.
15. Daar, E. S., and D. D. Ho. 1992. Variable HIV sensitivity to neutralization by recombinant soluble CD4. AIDS Res. Rev. 2:249-258.
16. Dragic, T., P. Chameau, F. Clavel, and M. Alizon. 1992. Complementation of murine cells for human immunodeficiency virus envelope/CD4-mediated fusion in human/murine heterokaryons. J. Virol. 66:4794-4802.
17. Durda, P. J., L. Bacheler, P. Clapham, A. M. Jenoski, B. Leece, T. J. Matthews, A. McKnight, R. Pomerantz, M. Rayner, and K. J. Weinhold. 1990. HIV-1 neutralizing monoclonal antibodies induced by a synthetic peptide. AIDS Res. Hum. Retroviruses 6:1115-1123.
18. Duzgunes, N. 1993. Membrane fusion techniques. Part A. Methods Enzymol. 220:1-433.
19. Duzgunes, N. 1993. Membrane fusion techniques. Part B. Methods Enzymol. 221:1-462.
20. Earl, P. L., N. Cooper, and B. Moss. 1991. Expression of proteins in mammalian cells using vaccinia viral vectors, p. 16.15.1-16.18.10. In F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology, vol. 2, suppl. 15. John Wiley & Sons, New York.
21. Earl, P. L., S. Koenig, and B. Moss. 1991. Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses. J. Virol. 65:31-41.
22. Eustice, D. C., P. A. Feldman, A. M. Colberg-Poley, R. M. Buckery, and R. H. Neubauer. 1991. A sensitive method for the detection of β-galactosidase in transfected mammalian cells. BioTechniques 11:739-742.
23. Fuerst, T. R., E. G. Niles, F. W. Studier, and B. Moss. 1986. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA 83:8122-8120.
24. Gallaher, W. R., L. A. Henderson, C. D. Fermin, R. C. Montelaro, A. Martin, M. N. Qureshi, J. M. Ball, Q. Sattentau, H. Luo-Zhang, and R. F. Garry. 1992. Membrane interactions of human immunodeficiency virus: attachment, fusion, and cytopathology. Adv. Membr. Fluid. 6:113-142.
25. Helseth, E., M. Kowalski, D. Gabuzda, U. Olshevsky, W. Haseltine, and J. Sodroski. 1990. Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants. J. Virol. 64:2416-2420.
26. Hoekstra, D., and M. C. P. de Lima. 1992. Molecular mechanisms of enveloped viruses entry into host cells: protein dynamics and membrane fusion. Adv. Membr. Fluid. 6:71-97.
27. Hu, X., Q. Yao, O. Morozova, and R. W. Compans. Association of the parainfluenza fusion and hemagglutinin-neuraminidase glycoproteins on cell surface. Submitted for publication.
28. Ito, M., M. Baba, A. Sato, R. Pauwels, E. Declercq, and S. Shigeta. 1987. Inhibitory effects of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitro. Antiviral Res. 7:361-367.
29. Kimpton, J., and M. Emerman. 1992. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene. J. Virol. 66:2232-2239.
30. Lamb, R. A. 1993. Paramyxovirus fusion: a hypothesis for changes. Virology 197:1-11.
31. Maddon, P. J., A. G. Dalgleish, J. S. McDougal, P. R. Clapham, R. A. Weiss, and R. Axel. 1986. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47:333-348.
32. Maddon, P. J., D. R. Littman, M. Godfrey, D. E. Maddon, L. Chess, and R. Axel. 1985. The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: a new member of the immunoglobulin gene family. Cell 42:93-104.
33. Moore, J. P., B. A. Jameson, R. A. Weiss, and Q. J. Sattentau. 1993. The HIV-cell fusion reaction, p. 233-289. In J. Bentz (ed.), Viral fusion mechanisms. CRC Press, Boca Raton, Fla.
34. 31a.Morgan, R. A. (National Center for Human Genome Research). Personal communication.
35. Moss, B. 1992. Molecular biology of poxviruses, p. 45-80. In M. M. Binns and G. L. Smith (ed.), Recombinant poxviruses. CRC Press, Boca Raton, Fla.
36. Moss, B., O. Elroy-Stein, T. Mizukami, W. A. Alexander, and T. R. Fuerst. 1990. New mammalian expression vectors. Nature (London) 348:91-92.
37. Munzer, J. S., J. R. Silvius, and R. Blostein. 1992. Delivery of ion pumps from exogenous membrane-rich sources into mammalian red blood cells. J. Biol. Chem. 267:5202-5210.
38. O'Brien, W. A., Y. Koyanagi, A. Namazie, J. Q. Zhao, A. Diagne, K. Idler, J. A. Zack, and I. S. Y. Chen. 1990. HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain. Nature (London) 348:69-73.
39. Page, K. A., N. R. Landau, and D. R. Littman. 1990. Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity. J. Virol. 64:5270-5276.
40. Ratner, L., W. Haseltine, R. Patarca, K. J. Livak, B. Starcich, S. F. Josephs, E. R. Doran, J. A. Rafalski, E. A. Whitehorn, K. Baumeister, L. Ivanoff, S. R. Petteway, M. L. Pearson, J. A. Lautenberger, T. S. Papas, J. Ghrayeb, N. T. Chang, R. C. Gallo, and F. Wong-Staal. 1985. Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature (London) 313:277-284.
41. Reiter, Z., Y. Reiter, Z. Fishelson, M. Shinitzky, A. Kessler, A. Loyter, O. Nussbaum, and M. Rubinstein. 1991. Resistance to NK cell-mediated cytotoxicity (in K-562 cells) does not correlate with class I MHC antigen levels. Immunobiology 183:23-39.
42. Rocancourt, D., C. Bonnerot, H. Jouin, M. Emerman, and J.-F. Nicolas. 1990. Activation of a β-galactosidase recombinant provirus: application to titration of human immunodeficiency virus (HIV) and HIV-infected cells. J. Virol. 64:2660-2668.
43. Sanchez-Pescador, R., M. D. Power, P. J. Barr, K. S. Steimer, M. M. Stempien, S. L. Brown-Shimer, W. W. Gee, A. Ranard, A. Randolph, J. A. Levy, D. Dina, and P. A. Luciw. 1985. Nucleotide sequence and expression of the AIDS-associated retrovirus (ARV-2). Science 227:484-492.
44. Skinner, M. A., R. Ting, A. J. Langlois, K. J. Weinhold, H. K. Lyerly, K. Javaherian, and T. J. Matthews. 1988. Characteristics of a neutralizing monoclonal antibody to the HIV envelope glycoprotein. AIDS Res. Hum. Retroviruses 4:187-197.
45. Usdin, T. B., M. J. Brownstein, B. Moss, and S. N. Isaacs. 1993. SP6 RNA polymerase containing vaccinia virus for rapid expression of cloned genes in tissue culture. BioTechniques 14:222-224.
46. Weiner, D. B., K. Huebner, W. V. Williams, and M. I. Greene. 1991. Human genes other than CD4 facilitate HIV-1 infection of murine cells. Pathobiology 59:361-371.